Scinovex
review Open AccessTop 1% cited

Prevalence of Asymptomatic SARS-CoV-2 Infection

Annals of Internal Medicine · 2020 · Vol. 173(5) · pp. 362–367
Daniel P. OranEric J. Topol

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.

COVID-19 epidemiological studiesSARS-CoV-2 detection and testingCOVID-19 Clinical Research StudiesAsymptomaticMedicineSubclinical infectionPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineCoronavirus disease 2019 (COVID-19)Public healthDiseasePediatrics

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2HumansPneumonia, ViralPrevalenceCoronavirus InfectionsAsymptomatic DiseasesPandemics
Citations
2,457
FWCI
79.31
field-weighted impact
References
19
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Prevalence of Asymptomatic SARS-CoV-2 Infection · Scinovex